Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study

NCT00781053 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Fibrosis

Interventions

DRUG: P144 cream

Sponsor

ISDIN

Collaborators

[object Object]